FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1998825128> ?p ?o ?g. }

• W1998825128 endingPage "670" @default.
• W1998825128 startingPage "661" @default.
• W1998825128 abstract "To determine the risk of, and risk factors for, developing cataracts after bone marrow transplantation.Four hundred and ninety-two adults who underwent bone marrow transplantation in Seattle were followed for 2 to 18 (median, 6) years. Before transplantation, patients received a preparative regimen of chemotherapy plus total body irradiation (TBI) (n = 407) or chemotherapy alone, without TBI (n = 85). TBI was administered in a single dose of 10 Gy (n = 74) or in fractionated doses totaling 12-15.75 Gy (n = 333). The risk of cataracts was determined for groups of patients with respect to the type of preparative regimen received and other pretransplant and posttransplant variables.One hundred and fifty-nine patients (32%) developed cataracts between 0.5 to 11 (median, 2.3) years after transplantation. The probability of cataracts at 11 years after transplantation was 85%, 50%, 34%, and 19% for patients receiving 10 Gy of single-dose TBI, > 12 Gy fractionated TBI, 12 Gy fractionated TBI, and no TBI, respectively (p < 0.0001). Among those developing cataracts, the severity was greater in patients after single-dose TBI (59% probability of surgical extraction) than after > 12 Gy fractionated TBI, 12 Gy fractionated TBI, or no TBI (33%, 22% and 23%, respectively). Patients given corticosteroids after transplant had a higher probability of cataracts (45%) than those without steroids (38%) (p < 0.0001). In a proportional hazards regression model, the variables that were correlated with an increased probability of cataracts were single-dose TBI (relative risk (RR) = 2.46) and steroid therapy (RR = 2.34), while a decreased probability of cataracts was correlated with a nonTBI preparative regimen (RR = 0.41). The yearly hazard of developing cataracts in recipients of single-dose TBI was highest during the third year after transplantation, while in recipients of fractionated TBI, the hazard was distributed among years one through seven. The probability of cataracts in all groups reached a plateau at 7 years after transplantation, after which the development of cataracts was extremely unlikely.TBI is the major risk factor for developing cataracts after BMT. Single-dose TBI results in the highest risk of cataracts. However, the risk of cataracts in recipients of fractionated-TBI is significantly higher than in patients who receive no TBI. In addition to TBI, steroid therapy is an independent risk factor for cataracts after BMT." @default.
• W1998825128 created "2016-06-24" @default.
• W1998825128 creator A5005532778 @default.
• W1998825128 creator A5010962133 @default.
• W1998825128 creator A5022931752 @default.
• W1998825128 creator A5030733029 @default.
• W1998825128 creator A5031125194 @default.
• W1998825128 creator A5032548674 @default.
• W1998825128 creator A5035391539 @default.
• W1998825128 creator A5037247107 @default.
• W1998825128 creator A5056405520 @default.
• W1998825128 creator A5070624070 @default.
• W1998825128 creator A5072857218 @default.
• W1998825128 creator A5085787488 @default.
• W1998825128 creator A5088481479 @default.
• W1998825128 creator A5089494498 @default.
• W1998825128 date "1995-06-01" @default.
• W1998825128 modified "2023-10-18" @default.
• W1998825128 title "Cataracts after bone marrow transplantation: Long-term follow-up of adults treated with fractionated total body irradiation" @default.
• W1998825128 cites W1562876511 @default.
• W1998825128 cites W1597544321 @default.
• W1998825128 cites W1974667448 @default.
• W1998825128 cites W1978729265 @default.
• W1998825128 cites W1981788556 @default.
• W1998825128 cites W1982769852 @default.
• W1998825128 cites W1990760791 @default.
• W1998825128 cites W1993010819 @default.
• W1998825128 cites W1993529515 @default.
• W1998825128 cites W1997900873 @default.
• W1998825128 cites W2011108545 @default.
• W1998825128 cites W2019636120 @default.
• W1998825128 cites W2053278212 @default.
• W1998825128 cites W2068611987 @default.
• W1998825128 cites W2069672941 @default.
• W1998825128 cites W2071349427 @default.
• W1998825128 cites W2096906680 @default.
• W1998825128 cites W2130871636 @default.
• W1998825128 cites W2135288559 @default.
• W1998825128 cites W2139710149 @default.
• W1998825128 cites W4293241248 @default.
• W1998825128 cites W5387557 @default.
• W1998825128 doi "https://doi.org/10.1016/0360-3016(94)00392-x" @default.
• W1998825128 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7790252" @default.
• W1998825128 hasPublicationYear "1995" @default.
• W1998825128 type Work @default.
• W1998825128 sameAs 1998825128 @default.
• W1998825128 citedByCount "103" @default.
• W1998825128 countsByYear W19988251282012 @default.
• W1998825128 countsByYear W19988251282013 @default.
• W1998825128 countsByYear W19988251282014 @default.
• W1998825128 countsByYear W19988251282015 @default.
• W1998825128 countsByYear W19988251282016 @default.
• W1998825128 countsByYear W19988251282018 @default.
• W1998825128 countsByYear W19988251282019 @default.
• W1998825128 countsByYear W19988251282020 @default.
• W1998825128 countsByYear W19988251282021 @default.
• W1998825128 countsByYear W19988251282022 @default.
• W1998825128 countsByYear W19988251282023 @default.
• W1998825128 crossrefType "journal-article" @default.
• W1998825128 hasAuthorship W1998825128A5005532778 @default.
• W1998825128 hasAuthorship W1998825128A5010962133 @default.
• W1998825128 hasAuthorship W1998825128A5022931752 @default.
• W1998825128 hasAuthorship W1998825128A5030733029 @default.
• W1998825128 hasAuthorship W1998825128A5031125194 @default.
• W1998825128 hasAuthorship W1998825128A5032548674 @default.
• W1998825128 hasAuthorship W1998825128A5035391539 @default.
• W1998825128 hasAuthorship W1998825128A5037247107 @default.
• W1998825128 hasAuthorship W1998825128A5056405520 @default.
• W1998825128 hasAuthorship W1998825128A5070624070 @default.
• W1998825128 hasAuthorship W1998825128A5072857218 @default.
• W1998825128 hasAuthorship W1998825128A5085787488 @default.
• W1998825128 hasAuthorship W1998825128A5088481479 @default.
• W1998825128 hasAuthorship W1998825128A5089494498 @default.
• W1998825128 hasConcept C118487528 @default.
• W1998825128 hasConcept C126322002 @default.
• W1998825128 hasConcept C141071460 @default.
• W1998825128 hasConcept C2776694085 @default.
• W1998825128 hasConcept C2776755627 @default.
• W1998825128 hasConcept C2778880498 @default.
• W1998825128 hasConcept C2780225610 @default.
• W1998825128 hasConcept C2781413609 @default.
• W1998825128 hasConcept C2911091166 @default.
• W1998825128 hasConcept C71924100 @default.
• W1998825128 hasConceptScore W1998825128C118487528 @default.
• W1998825128 hasConceptScore W1998825128C126322002 @default.
• W1998825128 hasConceptScore W1998825128C141071460 @default.
• W1998825128 hasConceptScore W1998825128C2776694085 @default.
• W1998825128 hasConceptScore W1998825128C2776755627 @default.
• W1998825128 hasConceptScore W1998825128C2778880498 @default.
• W1998825128 hasConceptScore W1998825128C2780225610 @default.
• W1998825128 hasConceptScore W1998825128C2781413609 @default.
• W1998825128 hasConceptScore W1998825128C2911091166 @default.
• W1998825128 hasConceptScore W1998825128C71924100 @default.
• W1998825128 hasIssue "3" @default.
• W1998825128 hasLocation W19988251281 @default.
• W1998825128 hasLocation W19988251282 @default.
• W1998825128 hasOpenAccess W1998825128 @default.
• W1998825128 hasPrimaryLocation W19988251281 @default.

• next